NICE recommends Lonsurf

The U.K.'s NICE released final draft guidance recommending Lonsurf trifluridine/tipiracil from Servier (Neuilly-sur-Seine, France) to treat metastatic colorectal cancer in patients previously treated with or who are not candidates for some chemotherapies, anti-VEGF agents and anti- EGFR therapies.

The recommendation is contingent on Servier providing Lonsurf at an undisclosed discount through a patient access scheme. ...